3 takeaways from PHTI report on AI medical scribes
Illustration: Brendan Lynch/Axios
AI-powered ambient scribes are experiencing one of the fastest tech adoption curves in health care history, especially in primary care settings.
Why it matters: Sector funding more than doubled to $800 million in 2024, compared with $390 million in 2023.
By the numbers: There are roughly 60 ambient scribes being implemented in medical practices, per a recent Peterson Health Technology Institute report.
What they're saying: When these tools successfully curb provider typing time, "it's a pure win," says Prabhjot Singh, PHTI senior advisor.
Here are three takeaways from Axios' interview with Singh.
Scribes rule primary care because of its verbal nature
What he's saying: Primary care is seeing the biggest scribe uptake due to the verbal nature of doctor-patient interactions.
Yes, but: Scribes struggle to adapt in surgical or complex specialty settings where silence or nuance rules the room.
Zoom in: For example, in pediatric neurology, a physician might spot a diagnosis but decline to say it aloud with family present, so the scribe wouldn't catch it.
- In another example, surgery, "there's almost no talking; you're just doing things," Singh says.
Bold roadmaps with lofty goals
What he's saying: Scribe companies are entering an identity crisis, with some angling to extend into billing or clinical reasoning.
Yes, but: Health systems aren't universally on board. Leaders are wary of vendors overreaching beyond their lane, especially if it means messing with revenue cycle management (RCM) setups already in place.
What's next: Don't count out a moonshot. Singh says he'd be shocked if the structure of the sector is the same in 10 to 15 years.
- Big changes tend to sneak up "from the corner of your eye," he adds.
It's unclear whether scribes cut costs
What he's saying: The financial impact of ambient scribes remains unclear, but Singh sees three major tests ahead to get closer to an answer.
- Whether they reduce the cost of bill collection.
- Whether they meaningfully improve patient experiences.
- Whether they can adapt to the diversity of provider needs and workflows.
The bottom line: "You can't actually scale and mature technology unless those questions really become answered," says Singh.
